Keywords: preotact, gets, eu, marketing, approval, usa-based, nps
Preotact gets EU Marketing approval
Article | 01 May 2006
USA-based NPS Pharmaceuticals and Danish drugmaker Nycomed say that the European Commission has granted marketing authorization for Preotact (parathyroid hormone [ ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Negative US patent ruling for Novo Nordisk on Prandin
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Daiichi Sankyo files for Japanese approval of Prasugrel
